Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
The Journal of Pediatrics
|
February 10, 2016
Safety of Everolimus in Patients Younger than 3 Years of Age: Results from EXIST-1, a Randomized, Controlled Clinical Trial
Sergiusz Jóźwiak, Katarzyna Kotulska, Noah Berkowitz, et al.
Pediatric Neurology
|
October 8, 2021
Prenatal Sirolimus Treatment for Rhabdomyomas in Tuberous Sclerosis
Daniel Ebrahimi-Fakhari, Gabrielle Stires, Eunice Hahn, et al.
Neurology
|
January 21, 2012
Everolimus alters white matter diffusion in tuberous sclerosis complex
Jan-Mendelt Tillema, James L Leach, Darcy A Krueger, et al.
Journal of Child Neurology
|
February 15, 2003
Supratentorial tuber location and autism in tuberous sclerosis complex
Nicolay Chertkoff Walz, Anna Weber Byars, John C Egelhoff, et al.
Journal of Child Neurology
|
July 19, 2012
Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex
David Neal Franz, Karen D Agricola, Cynthia A Tudor, et al.
Pediatric Neurology
|
January 12, 2020
Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex
Daniel Ebrahimi-Fakhari, Karen D Agricola, Cynthia Tudor, et al.
Journal of Child Neurology
|
March 23, 2006
Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial
James J Collins, Cynthia Tudor, Jennifer M Leonard, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
July 13, 2013
Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?
Gert Wiegand, Theodor W May, Philipp Ostertag, et al.
Pediatric Neurology
|
September 21, 2024
Mammalian Target of Rapamycin Inhibitor Levels Decrease Under Cenobamate Treatment
Lena-Luise Becker, Karen Agricola, David M Ritter, et al.
Neurology
|
January 18, 2013
Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma
Darcy A Krueger, Marguerite M Care, Karen Agricola, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
The Journal of Pediatrics
|
February 10, 2016
Safety of Everolimus in Patients Younger than 3 Years of Age: Results from EXIST-1, a Randomized, Controlled Clinical Trial
Sergiusz Jóźwiak, Katarzyna Kotulska, Noah Berkowitz, et al.
Pediatric Neurology
|
October 8, 2021
Prenatal Sirolimus Treatment for Rhabdomyomas in Tuberous Sclerosis
Daniel Ebrahimi-Fakhari, Gabrielle Stires, Eunice Hahn, et al.
Neurology
|
January 21, 2012
Everolimus alters white matter diffusion in tuberous sclerosis complex
Jan-Mendelt Tillema, James L Leach, Darcy A Krueger, et al.
Journal of Child Neurology
|
February 15, 2003
Supratentorial tuber location and autism in tuberous sclerosis complex
Nicolay Chertkoff Walz, Anna Weber Byars, John C Egelhoff, et al.
Journal of Child Neurology
|
July 19, 2012
Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex
David Neal Franz, Karen D Agricola, Cynthia A Tudor, et al.
Pediatric Neurology
|
January 12, 2020
Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex
Daniel Ebrahimi-Fakhari, Karen D Agricola, Cynthia Tudor, et al.
Journal of Child Neurology
|
March 23, 2006
Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial
James J Collins, Cynthia Tudor, Jennifer M Leonard, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
July 13, 2013
Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?
Gert Wiegand, Theodor W May, Philipp Ostertag, et al.
Pediatric Neurology
|
September 21, 2024
Mammalian Target of Rapamycin Inhibitor Levels Decrease Under Cenobamate Treatment
Lena-Luise Becker, Karen Agricola, David M Ritter, et al.
Neurology
|
January 18, 2013
Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma
Darcy A Krueger, Marguerite M Care, Karen Agricola, et al.
Page
of 4